Jeffrey A. Rona - Jul 30, 2024 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
CBFO
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
OVID
Transactions as of
Jul 30, 2024
Transactions value $
$0
Form type
4
Date filed
8/1/2024, 05:00 PM
Previous filing
Feb 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Employee Stock Option (right to buy) Award $0 +315K $0.00 315K Jul 30, 2024 Common Stock 315K $1.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares subject to the option shall vest on July 30, 2025, and the remaining shares subject to the option shall vest in 12 equal monthly installments thereafter, subject to Reporting Person's continuous service on each such date.